breakthrough ? : the scientists are now recruiting patients with skin cancer for the first clinical trial on humans . and it overcomes the problem of cancer presenting an ever-moving target that constantly evolves to evade the immune system . professor peter johnson , from the cancer research uk centre at southampton general hospital , said : ‘ this technique provides the first evidence that it may be possible to direct the immune system to fight cancer using personalised vaccines . ’